Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

MediChem-AstraZeneca collaboration extended

Aug. 9, 2000

No Comments

Research advances the use of transgenic plants to deliver vaccines

Aug. 8, 2000

No Comments

Scotia licenses rights to Techniclone's VTA technology for use in PDT

Aug. 7, 2000

No Comments

Aastrom Biosciences receives phase II SBIR award for UCB expansion system

Aug. 4, 2000

No Comments

Lexicon Genetics and Arena to develop GPCR modulators

Aug. 4, 2000

No Comments

Licensing opportunity from NIH: replication-deficient retroviral vectors

Aug. 3, 2000

No Comments

Adeno-associated virus vector available for licensing from NIH

Aug. 3, 2000

No Comments

Licensing opportunity from NIH: AAV4 and its use for gene delivery

Aug. 3, 2000

No Comments

Licensing opportunity from NIH: methods of gene targeting

Aug. 3, 2000

No Comments

New technology may improve safety in testing of adenovirus-based gene therapies

Aug. 3, 2000

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Drug design, drug delivery and technologies
RSS

MediChem-AstraZeneca collaboration extended

Research advances the use of transgenic plants to deliver vaccines

Scotia licenses rights to Techniclone's VTA technology for use in PDT

Aastrom Biosciences receives phase II SBIR award for UCB expansion system

Lexicon Genetics and Arena to develop GPCR modulators

Licensing opportunity from NIH: replication-deficient retroviral vectors

Adeno-associated virus vector available for licensing from NIH

Licensing opportunity from NIH: AAV4 and its use for gene delivery

Licensing opportunity from NIH: methods of gene targeting

New technology may improve safety in testing of adenovirus-based gene therapies

Today's news in brief

Today's news in brief

Proteomics study explores how protein changes influence disease

Type 1 diabetes breakthrough? Sana threads key ‘islet,’ SC-451 to advance

Australia’s Celosia heads toward clinic with gene therapy for ALS

Drug design, drug delivery and technologies RSS

Drug design, drug delivery and technologies
RSS